digital gene expression profiling
German bioinformatics startup 4HF Biotec targets early-stage biotech development with technology to predict drug sensitivity based on tumor genetic profiles.
NanoString Q3 Revenues Grow 4 Percent
The Seattle-based genomics technology firm saw revenues grow 20 percent on a pro forma basis, driven by 60 percent growth in instrument revenue.
NanoString Technologies Prices $200M Public Offering
The Seattle-based genomics technology firm said it intends to use the funds for working capital and general corporate purposes.
NanoString Launches NGS Readout for Spatial Transcriptomics, Partners With Illumina on Informatics
Premium
The firm has partnered with Illumina to use the Dragen Bio-IT informatics platform to help customers analyze data from the new Cancer Transcriptome Atlas panel.
NanoString Technologies Q2 Revenues Drop 25 Percent But Beat Street Estimates
The Seattle firm saw consumables and collaboration revenues fall, however, the GeoMx spatial transcriptomics platform grew instrument revenue.
Nov 4, 2019
NanoString Q3 Revenues Rise 7 Percent
Jul 31, 2019
NanoString Q2 Revenues up 21 Percent
May 9, 2019
NanoString Revenues Climb 18 Percent in Q1
Aug 22, 2013
Jun 8, 2010